NO20092078L - Fremgangsmate for behandling av alkoholmisbruk, adiksjon og avhengighet - Google Patents

Fremgangsmate for behandling av alkoholmisbruk, adiksjon og avhengighet

Info

Publication number
NO20092078L
NO20092078L NO20092078A NO20092078A NO20092078L NO 20092078 L NO20092078 L NO 20092078L NO 20092078 A NO20092078 A NO 20092078A NO 20092078 A NO20092078 A NO 20092078A NO 20092078 L NO20092078 L NO 20092078L
Authority
NO
Norway
Prior art keywords
addiction
treatment
procedure
alcohol abuse
abuse
Prior art date
Application number
NO20092078A
Other languages
English (en)
Inventor
Anil H Vaidya
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20092078L publication Critical patent/NO20092078L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er beskrevet fremgangsmåter for behandling av alkoholmisbruk, henfallenhet og/eller avhengighet, alene eller i kombinasjon med et eller flere antiavhengighetsmidler.
NO20092078A 2006-11-28 2009-05-28 Fremgangsmate for behandling av alkoholmisbruk, adiksjon og avhengighet NO20092078L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86137506P 2006-11-28 2006-11-28
PCT/US2007/084751 WO2008067177A2 (en) 2006-11-28 2007-11-15 Methods for the treatment of alcohol abuse, addiction and dependency

Publications (1)

Publication Number Publication Date
NO20092078L true NO20092078L (no) 2009-08-24

Family

ID=39345316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092078A NO20092078L (no) 2006-11-28 2009-05-28 Fremgangsmate for behandling av alkoholmisbruk, adiksjon og avhengighet

Country Status (15)

Country Link
US (1) US20080200492A1 (no)
EP (1) EP2101769B1 (no)
JP (1) JP2010511055A (no)
KR (1) KR20090087042A (no)
CN (1) CN101616669B (no)
AU (1) AU2007325365A1 (no)
CA (1) CA2672273C (no)
CO (1) CO6190520A2 (no)
EA (1) EA200970518A1 (no)
GT (1) GT200900139A (no)
IL (1) IL198792A0 (no)
MX (1) MX2009005640A (no)
NO (1) NO20092078L (no)
WO (1) WO2008067177A2 (no)
ZA (1) ZA200904455B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003268512A1 (en) * 2002-09-09 2004-03-29 Janssen Pharmaceutica N.V. Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
CN103202840B (zh) 2006-11-28 2015-02-11 詹森药业有限公司 3-(3-氨基-2-(r)-羟基-丙基)-1-(4-氟-苯基)-8-(8-甲基-萘-1-基甲基)-1,3,8-三氮杂-螺[4.5]癸烷-4-酮的盐
EP2150552B1 (en) 2007-04-09 2013-01-02 Janssen Pharmaceutica NV 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
CN104621437A (zh) * 2015-01-21 2015-05-20 胡家宁 一种用于抵抗酒精依赖的食品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
WO2002012401A2 (en) 2000-08-07 2002-02-14 Eastman Chemical Company Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups
AU2003268512A1 (en) * 2002-09-09 2004-03-29 Janssen Pharmaceutica N.V. Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders

Also Published As

Publication number Publication date
WO2008067177A2 (en) 2008-06-05
US20080200492A1 (en) 2008-08-21
CN101616669A (zh) 2009-12-30
EP2101769B1 (en) 2012-10-24
CA2672273C (en) 2016-01-12
CO6190520A2 (es) 2010-08-19
ZA200904455B (en) 2010-09-29
CA2672273A1 (en) 2008-06-05
MX2009005640A (es) 2009-06-05
GT200900139A (es) 2010-04-29
WO2008067177A3 (en) 2008-10-30
EP2101769A2 (en) 2009-09-23
AU2007325365A1 (en) 2008-06-05
IL198792A0 (en) 2010-02-17
EA200970518A1 (ru) 2009-12-30
KR20090087042A (ko) 2009-08-14
CN101616669B (zh) 2013-05-29
JP2010511055A (ja) 2010-04-08

Similar Documents

Publication Publication Date Title
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
WO2008003007A3 (en) Compositions and methods for treating parasitic infections
EP2214495A4 (en) NATURALLY PHOTODYNAMIC ACTIVE SUBSTANCES AND ITS USE
EP1835929B8 (en) Anti-kir combination treatments and methods
MX2009002496A (es) Combinaciones que contienen un derivado de 4-acilaminopiridina.
ATE551077T1 (de) Minderung einer infektion in zusammenhang mit einer medizinischen vorrichtung
PL2426220T3 (pl) Wyznakowane mikroorganizmy i sposoby wyznakowania
BRPI0717845A2 (pt) Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos
MX2022001510A (es) Nepicastat para usarse en el tratamiento de dependencia.
WO2009086471A3 (en) Synergistic antiparasitic compositions and screening methods
EP1901727A4 (en) METHODS OF TREATING ADDICTION AND DRUG DEPENDENCE
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
BRPI0911482A2 (pt) Uso de epotilona d no tratamento de doenças associadas a tau incluindo doenças de alzheimer
MY151051A (en) Vaccination against dengue virus infection
WO2007137224A3 (en) Method of treatment
NZ571858A (en) Methods of treating, reducing and inhibiting the appearance of ageing in the skin
PL1957973T3 (pl) System i sposób określania czasu, gdy stężenie alkoholu we krwi przekracza poziom progowy
NO20072890L (no) Behandling av mastitt
MX2009003022A (es) Composiciones y metodos para tratar picaduras de medusa.
NO20063987L (no) Anti-cancerterapier
WO2009023846A3 (en) Methods for heat shock protein dependent cancer treatment
WO2008115478A3 (en) Method of cancer detection and treatment
WO2008095122A3 (en) Methods of reducing 15-f2t-isop levels in mammals
MX2009005640A (es) Metodos para el tratamiento del abuso, adiccion y dependencia del alcohol.
AP2008004426A0 (en) SAF system and method involving specific treatments at respective stages

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application